NCT07065240: A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
- State
- Under way
- Phase
- Phase 2
- People
- 360 planned
- Started
- 19 Jun 2025
- Primary completion
- Mar 2027
- Arms
- SPT-300
- Results
- None posted
- 19 Jun 2025: Trial started
- 15 Jul 2025: Trial registered